InMode Ltd.

INMD Healthcare Medical Devices

InMode Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $370.5 million, down 6.16% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS fell 31.0% and free cash flow fell 12.6%, each against the same quarter a year earlier.

14.16 0.16 −1.12%
Market cap
$824.0M
P/E
11.3×
Fwd P/E
11.8×
Dividend yield
—
F-score
4/9
Altman Z
10.45
Beneish M
−2.25
Dividend safety
n/a
Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Piotroski F-Score
— — 7 5 7 4 4 4 4
P/E ratio
10.66 10.66 18.95 23.27 35.11 17.99 9.34 7.05 10.06
Altman Z-Score
— — 21.03 28.84 58.90 23.49 18.21 13.23 10.45
P/S ratio
2.96 2.96 7.33 8.31 16.08 6.40 3.77 3.35 2.56
P/FCF ratio
9.81 9.81 18.63 21.74 33.05 16.16 10.54 10.03 11.26
Altman Z″-Score (non-manufacturers)
7.38 8.47 13.56 15.82 17.32 16.63 20.97 19.00 18.86
Beneish M-Score
— (2.87) (2.25) (2.22) (1.58) (2.28) (1.93) (0.67) (2.25)
P/Operating CF
19.79 19.79 41.79 41.17 108.68 50.89 30.29 40.82 41.87
P/B ratio
6.62 6.62 6.37 6.70 13.82 5.24 2.36 1.88 1.39
Price to Tangible BV
6.62 6.62 6.37 6.70 13.82 5.24 2.36 1.88 1.39
EV/Sales
2.29 2.29 6.09 7.04 14.91 5.20 2.27 1.84 1.06
EV/EBITDA
7.96 7.96 15.90 19.81 31.74 11.89 5.68 6.43 4.58
EV/Operating CF
7.47 7.47 15.31 18.32 30.49 13.00 6.30 5.49 4.62
EV/FCF
7.59 7.59 15.48 18.43 30.66 13.12 6.33 5.51 4.68
Quick Ratio
2.39 2.41 6.27 7.84 8.66 7.19 12.48 9.38 8.83
Current Ratio
2.76 2.64 6.56 8.27 9.07 7.67 13.18 10.23 9.88
Net Debt/EBITDA
(2.74) (2.59) (3.23) (3.56) (2.48) (2.76) (3.78) (5.27) (6.45)
Debt/Assets
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt/Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Asset Turnover
0.89 1.66 1.04 0.80 0.92 0.81 0.65 0.48 0.48
Operating CF/Net income
1.66 1.65 1.02 1.06 1.06 1.12 0.89 0.73 0.91
Capex/Depreciation
(0.93) (2.07) (2.29) (1.11) (1.82) (2.32) (1.13) (0.92) (1.40)
ROE
28.12% 69.77% 54.48% 34.47% 49.15% 33.29% 29.50% 24.31% 13.53%
ROA
14.64% 37.13% 40.84% 29.19% 42.61% 28.77% 26.25% 21.99% 12.09%
ROIC
0.00% 0.00% 0.00% 0.00% 0.00% 1,709.17% 267.20% 65.52% 41.74%
Return on Tangible Assets
36.68% 45.77% 33.66% 29.36% 39.31% 29.39% 25.26% 28.02% 14.88%
Average Days of Receivables
48.30 34.63 24.37 24.92 33.86 33.82 43.49 54.02 68.21
Research and Development Expense of Revenue
4.82% 4.17% 3.64% 4.59% 2.67% 2.74% 2.73% 3.33% 3.59%
Selling, General and Administrative Expense of Revenue
61.50% 49.36% 45.28% 45.10% 35.73% 37.53% 41.11% 48.48% 51.89%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
4.56% 1.94% 1.00% 6.23% 3.35% 5.38% 4.80% 4.20% 3.00%
Graham Net Nets
0.18 0.18 0.15 0.15 0.07 0.19 0.41 0.48 0.65
Graham Number
0.00 2.82 8.46 9.02 15.20 17.22 22.47 21.75 18.63
Earnings Yield
9.38% 9.38% 5.28% 4.30% 2.85% 5.56% 10.71% 14.19% 9.94%
Free Cash Flow Yield
10.19% 10.19% 5.37% 4.60% 3.03% 6.19% 9.49% 9.97% 8.88%
Revenue per Share
1.02 1.88 2.67 2.86 4.39 5.51 5.89 4.98 5.73
Operating CF per Share
0.28 0.69 1.06 1.10 2.15 2.20 2.12 1.67 1.32
Capex per Share
0.00 (0.01) (0.01) (0.01) (0.01) (0.02) (0.01) (0.01) (0.01)
Free Cash Flow per Share
0.27 0.69 1.05 1.09 2.14 2.18 2.11 1.66 1.30
Cash per Share
0.48 1.15 3.31 3.61 5.11 6.64 8.88 7.52 8.59
Shareholders Equity per Share
0.37 0.84 3.08 3.54 5.11 6.72 9.43 8.87 10.57
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
0.37 0.84 3.08 3.54 5.11 6.72 9.43 8.87 10.57
Free Cash Flow
14.42 36.51 61.51 78.76 173.95 180.00 176.12 132.00 84.29
Working Capital
23.69 48.34 180.71 254.56 418.26 547.35 781.19 644.60 627.88
Capital Expenditures
(0.19) (0.38) (0.69) (0.46) (0.94) (1.57) (0.70) (0.67) (0.97)
Net Current Asset Value
17.16 41.38 174.63 249.31 407.38 539.58 769.42 632.60 615.39
EV/EBIT
8.01 8.01 15.98 19.93 31.84 11.93 5.70 6.47 4.62
Capex to Sales
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Operating Income
10.35 10.35 19.22 23.50 34.32 14.70 9.49 11.77 11.12
Other line items
Depreciation/Fixed assets
0.59 0.34 0.32 0.42 0.37 0.30 0.26 0.31 0.27
Cash ROIC
32.41% 34.45% 16.48% 15.26% 20.91% 16.33% 11.52% 10.15% 6.81%
Accounts Receivable Turnover
6.45 12.08 15.68 16.82 15.14 12.07 9.77 6.75 5.80
Accounts Payable Turnover
2.39 3.98 4.93 6.10 7.06 5.87 5.34 5.60 5.02
Inventory Turnover
1.51 2.51 2.47 2.53 2.98 2.41 1.90 1.49 1.19
Average Days of Payables
123.53 109.30 66.77 75.84 59.79 80.67 63.16 64.70 82.21
Days of Inventory on Hand
203.00 168.79 169.68 177.28 143.20 198.17 203.94 279.54 339.87
Average Receivables
8.29 8.29 9.97 12.26 23.62 37.63 50.36 58.53 63.83
Average Payables
3.79 3.79 4.11 5.06 7.59 12.51 15.10 13.87 15.85
Average Inventory
6.00 6.00 8.19 12.20 18.00 30.46 42.50 52.32 66.80
Average Assets
60.25 60.25 149.72 257.07 387.15 561.48 753.85 824.48 776.05
Average Common Equity
31.36 32.06 112.24 217.64 335.64 485.21 671.00 745.59 693.51

Fold the line items

Columns are period end dates